Case Study: Discussing the Regulatory Pathway to Clinic

By | 12 March 2026
  • Highlighting the journey of advancing gene-edited iPSC therapies from preclinical to clinical trials, sharing lessons learned and insights on meeting regulatory and CMC expectations